Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MERCK Kommanditgesellscha...

    OTC: MKGAF · Real-Time Price · USD
    135.44
    -0.81 (-0.59%)
    At close: Jun 13, 2025, 3:56 PM
    -0.59%
    Bid 129
    Market Cap 58.89B
    Revenue (ttm) 21.16B
    Net Income (ttm) 2.78B
    EPS (ttm) 7.41
    PE Ratio (ttm) 18.28
    Forward PE n/a
    Analyst n/a
    Ask 136
    Volume 129
    Avg. Volume (20D) 1,026
    Open 130.94
    Previous Close 136.25
    Day's Range 130.94 - 135.44
    52-Week Range 118.05 - 200.56
    Beta 0.64

    About MKGAF

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol MKGAF
    Website n/a
    Full Company Profile
    news image

    3 days ago · businesswire.com

    China's Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor

    DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical P...

    news image

    1 month ago · seekingalpha.com

    Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript

    Merck KGaA (OTCPK:MKGAF) Q1 2025 Earnings Call May 15, 2025 8:00 AM ET Company Participants Florian Schraeder - Head, Investor Relations Belen Garijo - Group Chief Executive Officer Helene von Roeder ...

    news image

    1 month ago · reuters.com

    Germany's Merck drops China surcharge on orders after US-China tariff deal

    German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China following the U.S.-China agreement to pause sky-high tariffs on each other, the com...

    news image

    1 month ago · proactiveinvestors.co.uk

    Merck KGaA swoops for US group SpringWorks in $3.4bn deal

    Germany's Merck KGaA has agreed to acquire US biotech firm SpringWorks Therapeutics for $3.9 billion in cash. The deal, announced on Monday, values SpringWorks at $47 a share and reflects an enterpris...

    news image

    1 month ago · wsj.com

    Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal

    The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.

    news image

    1 month ago · reuters.com

    Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks

    German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech firm SpringWorks Therapeutics for an equity value of $3.9 billion to boost its cancer drug busi...

    Add to Watchlist